Login / Signup

Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation.

Elaine M PascoeSteven J ChadbanMagid A FahimCarmel M HawleyDavid W JohnsonMichael G Collinsnull null
Published in: Trials (2022)
Australian New Zealand Clinical Trials Registry ACTRN12617000358347 . Prospectively registered on 8 March 2017 ClinicalTrials.gov identifier NCT03829488 . Registered on 4 February 2019.
Keyphrases
  • kidney transplantation
  • clinical trial
  • risk factors
  • high dose
  • randomized controlled trial
  • open label
  • mesenchymal stem cells
  • cell therapy
  • study protocol
  • replacement therapy